A carregar...
The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
Apomorphine is now recognized as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed in Europe for patients with advanced Parkinson’s disease (PD) with motor fluctuations. However, its history is far from being limited to movement disorders. This pap...
Na minha lista:
| Publicado no: | Drugs R D |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5995787/ https://ncbi.nlm.nih.gov/pubmed/29546602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0230-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|